Bahrain vs Lebanon: HIV-positive TB patients on ART (antiretroviral therapy)
Bahrain
100.0%
in 2023
Lebanon
100.0%
in 2024
Bahrain rank
1st
Lebanon rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Bahrain
- Lebanon
How they compare
Bahrain currently reports 100.0% against 100.0% in Lebanon, a difference of 0.0%.
The two have swapped places 3 times across 11 shared years of data; in 2008 it was Lebanon ahead.
Bahrain ranks 1st and Lebanon ranks 1st of 144 countries.
Lebanon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bahrain | Lebanon | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.0% | 100.0% | 87.0% | Lebanon |
| 2010s | 66.2% | 80.8% | 14.7% | Lebanon |
| 2020s | 56.7% | 89.0% | 32.3% | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Bahrain or Lebanon?
- Bahrain, at 100.0% against 100.0% in Lebanon as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Bahrain and Lebanon?
- 0.0%, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Lebanon?
- 11 years are reported by both, from 2008 to 2023.
- How do Bahrain and Lebanon rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Bahrain ranks 1st and Lebanon ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.